Tutorials › Generalized Linear Mixed Models (GLMM) › Diagnosing Random-Slope Convergence Problems

Convergence, Singular Fits and Boundary Estimates · Tutorial 312 of 698

Diagnosing Random-Slope Convergence Problems

Use model-scale checks and the predictor’s within-group pattern to investigate random-slope convergence warnings without confusing numerical problems with limited information.

Advanced 12 min read

What You'll Learn

  • Write a random-intercept and random-slope GLMM and state its core assumptions.
  • Trace how centering and scaling transform fixed effects and the random-effect covariance matrix.
  • Assess whether groups contain enough within-group predictor variation to inform a random slope.
  • Interpret gradients, Hessian diagnostics, and covariance estimates cautiously.
  • Distinguish a change in numerical parameterization from a change in the model.
  • Apply a structured diagnostic sequence to a hypothetical convergence warning.

Why Random-Slope Fits Need Targeted Diagnosis

A random-slope GLMM allows the relationship between a predictor and the outcome to vary across groups. That flexibility can be scientifically important, but it also asks the data to estimate more than a random-intercept model does: variation in group-specific slopes, their relationship with group-specific intercepts, and the fixed effects that describe the average relationship. A convergence warning can therefore reflect numerical scaling, a difficult covariance estimate, or limited variation in the predictor within groups. Those causes are not interchangeable, and they do not have the same remedy.

The goal of diagnosis is not to make a warning disappear at any cost. It is to determine whether the fitted model has been optimized reliably and whether the observed design contains information to estimate the random-slope terms. The earlier material on covariance parameterization and numerical stability, design-based identifiability in clustered data, and line search and failed optimization steps provides useful context; here the emphasis is on how those issues appear specifically in random-slope fits.

Model and Assumptions

Let \(y_{ij}\) denote the response for observation \(j\) in group \(i\), and let \(x_{ij}\) be a predictor that may vary within groups. For clarity, consider a GLMM with one random intercept and one random slope:

$$ g\{E(Y_{ij}\mid b_i)\} =\beta_0+\beta_1x_{ij}+b_{0i}+b_{1i}x_{ij}, \qquad \begin{pmatrix}b_{0i}\\b_{1i}\end{pmatrix} \sim N\left( \begin{pmatrix}0\\0\end{pmatrix}, D \right), \qquad D= \begin{pmatrix} \tau_0^2 & \tau_{01}\\ \tau_{01} & \tau_1^2 \end{pmatrix}. $$

Here \(g\) is the chosen link, \(\beta_0\) and \(\beta_1\) are fixed effects, and \(D\) is the random-effects covariance matrix. For example, a binary response may use the logit link. The group-specific slope on the linear-predictor scale is \(\beta_1+b_{1i}\). This model assumes that groups’ random-effect vectors are independent draws from a common mean-zero multivariate normal distribution, and that responses are conditionally independent given the random effects and the model covariates. The conditional response distribution and link must be appropriate for the outcome. The predictor values are treated as observed design values for the diagnostic reasoning below.

Key diagnostic distinction: A convergence warning is about the numerical fitting process; weakly identified or boundary covariance estimates concern what the data can support. A warning alone does not establish which problem is present, and a fit without a warning is not proof that the model is well identified.

First Check the Predictor’s Scale

A random slope is expressed in units of \(x\). If \(x\) is recorded in very large or very small units, the corresponding slope and covariance parameters can also have awkward numerical magnitudes. This can make optimization less stable even when the underlying model is reasonable. A global shift and rescaling can help, provided the random-effects structure is transformed along with the predictor.

For a constant \(c\) and positive scale \(s\), define \(x^*=(x-c)/s\), so \(x=c+sx^*\). Substituting this into the linear predictor gives:

$$ \beta_0+\beta_1x+b_{0i}+b_{1i}x = (\beta_0+c\beta_1)+s\beta_1x^* +(b_{0i}+cb_{1i})+sb_{1i}x^*. $$

Thus \(\beta_0^*=\beta_0+c\beta_1\), \(\beta_1^*=s\beta_1\), \(b_{0i}^*=b_{0i}+cb_{1i}\), and \(b_{1i}^*=sb_{1i}\). In matrix form, \(b_i^*=A b_i\), where \(A=\begin{pmatrix}1&c\\0&s\end{pmatrix}\). Consequently, the transformed covariance matrix is \(D^*=ADA^\mathsf{T}\). With an unrestricted intercept-slope covariance, this is a re-expression of the same model, not a change in its fitted predictions.

Worked Example: Centering and Scaling a Time Predictor

Suppose a hypothetical repeated-measures study records time \(x\) in hours, and the fitted random-effects covariance matrix on that scale is \(D=\begin{pmatrix}4&-0.2\\-0.2&0.04\end{pmatrix}\). For improved numerical scale, define \(x^*=(x-10)/5\), so \(c=10\) and \(s=5\). Find the transformed covariance matrix and explain what changes.

The transformation matrix is \(A=\begin{pmatrix}1&10\\0&5\end{pmatrix}\). First, the transformed random intercept is \(b_{0i}^*=b_{0i}+10b_{1i}\), and the transformed random slope is \(b_{1i}^*=5b_{1i}\). Therefore:

$$ D^*=ADA^\mathsf{T} = \begin{pmatrix} 1&10\\0&5 \end{pmatrix} \begin{pmatrix} 4&-0.2\\-0.2&0.04 \end{pmatrix} \begin{pmatrix} 1&0\\10&5 \end{pmatrix} = \begin{pmatrix}4&1\\1&1\end{pmatrix}. $$

For instance, the upper-left entry is \(\operatorname{Var}(b_{0i}+10b_{1i})=4+20(-0.2)+100(0.04)=4\); the transformed covariance is \(5[-0.2+10(0.04)]=1\), and the slope variance is \(25(0.04)=1\). The covariance values and correlation have changed because the intercept is now defined at 10 hours and the slope is per 5 hours. The group-specific linear predictors have not changed. A changed covariance report after rescaling is therefore not, by itself, evidence that the model’s substantive fit changed.

Centering at a meaningful value can also make the intercept easier to interpret and may reduce numerical coupling between intercept and slope. However, centering and scaling are diagnostic tools, not cures for missing information. In particular, centering each group at a different group-specific mean is not generally the same common affine reparameterization: it can change the implied random-effects covariance assumptions. Do not treat that operation as a purely numerical change without checking the model it defines.

Check Within-Group Predictor Variation

A random slope describes how the predictor-outcome relationship varies across groups. Estimating that variation requires information about the predictor’s relationship with outcomes within groups, not merely a wide range of predictor values across the entire data set. If a predictor is constant within a group, that group cannot directly reveal how the response changes with the predictor as it varies there. When nearly all groups have little within-group variation, slope and intercept contributions can be difficult to distinguish.

A useful design check is to tabulate, by group, the number of observations and the range or standard deviation of \(x\). This does not test whether the random slope is appropriate, and there is no universal minimum range that guarantees adequate information. It reveals where the design does and does not provide within-group contrast. Outcome patterns, the link, and the distribution of observations also affect the information available.

Worked Example: Locating the Groups That Inform a Slope

In a hypothetical design, four groups have predictor values as follows: group A has \(0,0,0\); group B has \(1,1,1\); group C has \(0,1,2\); and group D has \(0,1,2\). Assess the within-group variation relevant to a random slope.

Groups A and B each have range \(0\) and within-group sample variance \(0\). In each of groups C and D, the mean is \(1\), and the within-group sample variance is \(\{(0-1)^2+(1-1)^2+(2-1)^2\}/(3-1)=2/2=1\). Thus only two of the four groups have predictor variation.

Across C and D, the within-group sum of squared deviations is \(2+2=4\); A and B contribute \(0\). Although the predictor takes multiple values across the full data set, much of that overall variation comes from differences between groups A and B, not changes within those groups. The random-slope information is therefore concentrated in C and D. With only two groups contributing within-group contrast, a slope variance and intercept-slope covariance may be weakly supported. This calculation is a design warning, not proof that the model cannot be estimated: the outcome data and the full design still matter.

Interpreting Covariance and Optimization Diagnostics

The random intercept and slope are estimated jointly. Their covariance can create a difficult likelihood surface, especially when parameters are near a boundary or when the data provide limited information about one direction of variation. Earlier material on random-effect variances near zero, singular covariance matrices, and correlations near plus or minus one explains those boundary patterns. In this tutorial, the practical point is to inspect those estimates alongside the predictor scale and design, rather than attributing every warning to the optimizer alone.

Review the optimizer’s reported convergence status, gradient information, and curvature diagnostics in the parameterization actually fitted. A large gradient relative to the software’s stated tolerance means the objective may not be sufficiently stationary under that criterion. A Hessian or curvature warning can indicate a flat or poorly determined direction, but its interpretation depends on how the software calculates and scales it. Tolerances and gradient definitions differ across implementations; a numerical threshold is not universal. Compare results across optimizers or starting values when warranted, using the earlier material on comparing optimizers and choosing convergence tolerances. Agreement is reassuring, but cannot supply information the design lacks.

Diagnostic principle: After a scale change, compare the implied estimates on a common parameterization and compare fitted linear predictors or likelihood values, not raw coefficient values alone. A smaller gradient in a new parameterization is useful evidence about numerical behavior, but does not establish that the random-slope variance is well estimated.

Worked Example: Separating a Scaling Warning From a Design Limitation

Suppose a hypothetical binary-outcome GLMM uses time in minutes, with a logit link and a random intercept and slope. The predictor ranges from 0 to 120 minutes. One fit reports a maximum scaled gradient of \(0.018\), above the software’s stated tolerance of \(0.001\). After defining \(x^*=(x-60)/60\), a refit reports \(0.0003\). The estimates on the original scale are \(\hat{\beta}_0=-1.30\) and \(\hat{\beta}_1=0.012\) per minute, with random-slope standard deviation \(0.004\) per minute. What can be concluded?

The transformed fixed effects implied by the original estimates are \(\hat{\beta}_0^*=\hat{\beta}_0+60\hat{\beta}_1=-1.30+60(0.012)=-0.58\), and \(\hat{\beta}_1^*=60\hat{\beta}_1=0.72\) per unit of \(x^*\). The transformed random-slope standard deviation is \(60(0.004)=0.24\) per unit of \(x^*\). These are the parameter-scale changes expected from the global affine transformation.

The smaller reported gradient is evidence that scaling may have improved the numerical optimization under the software’s diagnostic. It is not enough, on its own, to declare the problem solved. Check that transformed estimates map back consistently, the likelihood and fitted predictions agree to numerical precision, and other diagnostics do not indicate problematic curvature or covariance estimates. Then inspect the group-wise time ranges. If most groups contain observations at only one time, the improved optimization does not create the missing within-group information needed to estimate slope variation reliably. The gradient values are hypothetical output, and their interpretation is relative to the stated implementation and tolerance.

A Practical Diagnostic Sequence

A useful sequence keeps numerical checks and design checks connected while distinguishing them. It does not assume that every warning has a single cause.

1
Verify the fitted model and warning.
Confirm the predictor, link, grouping structure, random-effects specification, optimizer status, and the software’s definition of the reported diagnostic. Record the scale on which the predictor and parameters were fitted.
2
Inspect the design within groups.
Tabulate group sizes and predictor ranges or standard deviations. Identify whether within-group variation is widespread or concentrated in a few groups; do not infer slope information from the overall predictor range alone.
3
Check scale and covariance behavior.
Consider a clearly documented global centering or scaling transformation. Inspect the random-effect variances and covariance, including boundary or near-boundary behavior, in the parameterization being used.
4
Refit and compare on a common scale.
Assess convergence diagnostics, curvature, likelihood, and fitted values. Map coefficients and covariance estimates back using the transformation formulas; do not compare untransformed numerical values as if their units were unchanged.
5
State what the checks establish.
Report whether evidence points mainly to scale sensitivity, weak within-group information, or unresolved optimization. If the evidence remains ambiguous, describe the uncertainty rather than treating a warning-free fit as definitive.

Common Pitfalls, Alternatives, and Limits

  • “The overall predictor range is broad, so the random slope is identified.” Overall range can arise from differences between groups. Check the predictor’s variation within groups.
  • “Rescaling changed the random-effects correlation, so it changed the scientific result.” Intercept-slope covariance and correlation depend on the predictor’s origin and units. Compare equivalent fitted predictions and transformed parameters.
  • “The warning disappeared, so the slope variance is trustworthy.” A warning concerns an optimization diagnostic; it does not certify the information content of the design or the precision of covariance estimates.
  • “A group-mean-centered predictor is always just a numerically improved version.” Group-specific centering can change the implied covariance structure. Check whether it preserves the model assumptions and scientific estimand before using it.

The main diagnostic alternatives answer different questions. Rescaling tests whether numerical behavior is sensitive to parameter units; refitting with another optimizer tests sensitivity to the optimization route; inspecting within-group variation assesses the design’s ability to inform the slope. These checks complement one another. None alone proves that the random-effects specification is scientifically appropriate, and this diagnostic sequence does not decide whether a model should be simplified. Such a decision requires evaluating the intended model and the consequences of changing its random-effects structure, not merely removing a warning.

Key takeaway: Diagnose a random-slope warning by connecting the optimizer’s numerical evidence to the predictor’s units, covariance estimates, and within-group variation. A scale change can improve computation; it cannot replace information absent from the design.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. A predictor is measured in seconds and ranges from 0 to 3,600. What information should be checked before concluding that its scale explains a random-slope warning?
  2. If \(x^*=(x-4)/2\), express the transformed random intercept and random slope in terms of \(b_{0i}\) and \(b_{1i}\).
  3. Every group has many observations, but in each group the predictor is constant. Does the large group size alone establish good within-group information for a random slope?
  4. After rescaling, a fit has a smaller gradient but a near-boundary random-slope variance. What does the smaller gradient establish, and what does it not establish?

Solutions. (1) Check the units and distribution of \(x\), group-wise ranges or standard deviations, the software’s gradient definition and tolerance, covariance diagnostics, and whether rescaled estimates map back consistently. A large overall range alone does not establish that groups have within-group variation. (2) Since \(x=4+2x^*\), substitution gives \(b_{0i}^*=b_{0i}+4b_{1i}\) and \(b_{1i}^*=2b_{1i}\). (3) No. Repeated observations at one predictor value within a group do not supply within-group predictor contrasts; group size alone does not guarantee information about slope variation. (4) The smaller gradient is evidence of improved stationarity under that parameterization and diagnostic. It does not establish that the variance is well identified, away from a boundary, or supported by adequate within-group variation.

Clinical Biostats